cgp 42112a has been researched along with trandolapril in 1 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (trandolapril) | Trials (trandolapril) | Recent Studies (post-2010) (trandolapril) |
---|---|---|---|---|---|
233 | 0 | 35 | 541 | 214 | 71 |
Protein | Taxonomy | cgp 42112a (IC50) | trandolapril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.0009 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campan, M; Costerousse, O; Desgranges, C; Gadeau, AP; Millet, D | 1 |
1 other study(ies) available for cgp 42112a and trandolapril
Article | Year |
---|---|
Effects of angiotensins on cellular hypertrophy and c-fos expression in cultured arterial smooth muscle cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Biphenyl Compounds; Captopril; Cells, Cultured; DNA; Imidazoles; Indoles; Losartan; Muscle, Smooth, Vascular; Oligopeptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred WKY; RNA; Tetrazoles | 1992 |